Alexandros Makriyannis
Affiliations: | 1974- | Medicinal Chemistry | University of Connecticut, Storrs, CT, United States |
| 2004- | Northeastern University, Boston, MA, United States |
Area:
BiochemistryWebsite:
https://www.ellines.com/en/famous-greeks/30216-pioneer-in-chemical-biology/Google:
"Alexandros Makriyannis"Bio:
https://bouve.northeastern.edu/directory/alexandros-makriyannis/
https://bouve.northeastern.edu/assets/uploads/2014/07/alexandros_makriyannis_cv.pdf
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Edward Ervin Smissman | grad student | 1967 | University of Kansas | |
| (Part I : a chemical approach to schizophrenia : Part II : azodicarboxylic acid esters as dealkylating agents : a mechanistic study.) | ||||
| Henry Rapoport | post-doc | 1967-1969 | UC Berkeley | |
Children
Sign in to add trainee| Stephen Walter Fesik | grad student | 1981 | University of Connecticut |
| Hongfeng Deng | grad student | 2000 | University of Connecticut |
| Andreas Goutopoulos | grad student | 2000 | University of Connecticut |
| Jianxin Guo | grad student | 2004 | University of Connecticut |
| Xinzhong Lai | grad student | 2005 | University of Connecticut |
| Ravi Chari | grad student | 2006 | University of Connecticut |
| Jenine K. Sanzari | grad student | 2006 | University of Connecticut |
| Suma Yaddanapudi | grad student | 2007 | University of Connecticut |
| Manjunath Lamani | post-doc | Northeastern University | |
| Chinnasamy Ramaraj Ramanathan | post-doc | University of Connecticut |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Malamas MS, Lamani M, Farah SI, et al. (2021) Design and Synthesis of Highly Potent and Specific ABHD6 Inhibitors. Chemmedchem |
| Ho TC, Tius MA, Nikas SP, et al. (2021) Oxa-Adamantyl Cannabinoids. Bioorganic & Medicinal Chemistry Letters. 127882 |
| Kokona D, Spyridakos D, Tzatzarakis M, et al. (2021) The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity. Neuropharmacology. 185: 108450 |
| Wooldridge LM, Ji L, Liu Y, et al. (2020) Antiemetic Effects of Cannabinoid Agonists in Nonhuman Primates. The Journal of Pharmacology and Experimental Therapeutics |
| Hua T, Li X, Wu L, et al. (2020) Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G Complex Structures. Cell |
| Malamas MS, Farah SI, Lamani M, et al. (2019) Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors. Bioorganic & Medicinal Chemistry. 115195 |
| Kangas BD, Zakarian AS, Vemuri K, et al. (2019) Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates. The Journal of Pharmacology and Experimental Therapeutics |
| Lamani M, Malamas MS, Farah SI, et al. (2019) Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology. Bioorganic & Medicinal Chemistry. 115096 |
| Alapafuja SO, Nikas SP, Ho TC, et al. (2019) Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor. Molecules (Basel, Switzerland). 24 |
| Salaga M, Binienda A, Tichkule RB, et al. (2019) Corrigendum to "The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome" [Eur. J. Pharmacol. (2018), 836 34-43]. European Journal of Pharmacology. 172656 |